We are live on !
Find out more
&Partners Portfolio holdings
AUM
$24.4B
Turnover
11.02%
1-Year Est. Return
27.45%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+27.45%
3 Year Est. Return
+78.37%
5 Year Est. Return
+81.51%
10 Year Est. Return
–
AUM
$24.4B
AUM Growth
+$4.13B
(+20%)
Cap. Flow
+$1.89B
Cap. Flow % of AUM
Cap. Flow %
7.77%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
2,595
New
200
Increased
1,495
Reduced
755
Closed
86
Avg Time Held
1.5
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$71M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$62.1M |
| 3 |
Apple
AAPL
|
+$55.3M |
| 4 |
Microsoft
MSFT
|
+$44.6M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$41.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$14.1M |
| 2 |
First Trust Indxx Aerospace & Defense ETF
MISL
|
+$14M |
| 3 |
Procter & Gamble
PG
|
+$13.9M |
| 4 |
First Trust Energy AlphaDEX Fund
FXN
|
+$13.7M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.56% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.64% |
| 4 | Industrials | 5.77% |
| 5 | Healthcare | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1651
Canadian Imperial Bank of Commerce
CM
$103B
| $685K | ﹤0.01% |
5,958
-358
| -6% | -$39.3K |
2024 Q2
8 quarters
|
|
1652
Laureate Education
LAUR
$5.36B
| $684K | ﹤0.01% |
+18,835
| New | +$636K |
2026 Q2
0 quarters
|
|
1653
Noble Corp
NE
$7.43B
| $683K | ﹤0.01% |
18,316
+1,762
| +11% | +$84.2K |
2025 Q3
3 quarters
|
|
1654
iShares Core MSCI Europe ETF
IEUR
$9.26B
| $683K | ﹤0.01% |
9,088
+5,585
| +159% | +$416K |
2025 Q4
2 quarters
|
|
1655
Kimball Electronics
KE
$595M
| $683K | ﹤0.01% |
26,665
-1,788
| -6% | -$45.9K |
2024 Q3
7 quarters
|
|
1656
Everest Group
EG
$15.5B
| $680K | ﹤0.01% |
1,904
-20
| -1% | -$6.85K |
2025 Q2
4 quarters
|
|
1657
Royal Gold
RGLD
$19.6B
| $680K | ﹤0.01% |
3,364
+1,110
| +49% | +$258K |
2026 Q1
1 quarter
|
|
1658
Western Midstream Partners
WES
$18.6B
| $677K | ﹤0.01% |
15,476
-1,060
| -6% | -$45.7K |
2025 Q2
4 quarters
|
|
1659
NetEase
NTES
$75.6B
| $676K | ﹤0.01% |
5,285
+384
| +8% | +$45.3K |
2024 Q4
6 quarters
|
|
1660
Calamos Convertible and High Income Fund
CHY
$900M
| $676K | ﹤0.01% |
49,606
+19,078
| +62% | +$241K |
2025 Q3
3 quarters
|
|
1661
KraneShares CSI China Internet ETF
KWEB
$4.31B
| $674K | ﹤0.01% |
27,551
+15,139
| +122% | +$419K |
2024 Q3
7 quarters
|
|
1662
Centrus Energy
LEU
$2.08B
| $674K | ﹤0.01% |
3,741
+1,763
| +89% | +$329K |
2026 Q1
1 quarter
|
|
1663
Unifirst Corp
UNF
$5.03B
| $672K | ﹤0.01% |
2,541
-1,438
| -36% | -$376K |
2024 Q4
6 quarters
|
|
1664
Revolution Medicines
RVMD
$39.8B
| $671K | ﹤0.01% |
+3,474
| New | +$507K |
2026 Q2
0 quarters
|
|
1665
Avery Dennison
AVY
$13.8B
| $668K | ﹤0.01% |
4,115
-227
| -5% | -$37K |
2024 Q3
7 quarters
|
|
1666
Cohen & Steers Quality Income Realty Fund
RQI
$1.52B
| $668K | ﹤0.01% |
54,257
+1,710
| +3% | +$22.2K |
2024 Q4
6 quarters
|
|
1667
Bio-Rad Laboratories Class A
BIO
$9.6B
| $668K | ﹤0.01% |
2,274
-65
| -3% | -$18.4K |
2024 Q3
7 quarters
|
|
1668
BlackRock MuniHoldings Fund
MHD
$1.82B
| $664K | ﹤0.01% |
54,778
+7,064
| +15% | +$82.5K |
2025 Q4
2 quarters
|
|
1669
Astrana Health
ASTH
$1.86B
| $664K | ﹤0.01% |
14,314
+2,618
| +22% | +$94.2K |
2025 Q4
2 quarters
|
|
1670
Nutrien
NTR
$33.1B
| $661K | ﹤0.01% |
10,508
+233
| +2% | +$16.3K |
2024 Q4
6 quarters
|
|
1671
Luxfer Holdings
LXFR
$466M
| $660K | ﹤0.01% |
36,592
-1,978
| -5% | -$30.9K |
2024 Q3
7 quarters
|
|
1672
EchoStar
ECHO
$25.5B
| $660K | ﹤0.01% |
6,573
+1,862
| +40% | +$228K |
2025 Q4
2 quarters
|
|
1673
Jefferies Financial Group
JEF
$10.2B
| $660K | ﹤0.01% |
13,440
+3,207
| +31% | +$165K |
2024 Q3
7 quarters
|
|
1674
VanEck Agribusiness ETF
MOO
$1.1B
| $660K | ﹤0.01% |
8,327
-290
| -3% | -$23.6K |
2026 Q1
1 quarter
|
|
1675
Federated Hermes Short Duration High Yield ETF
FHYS
$60.8M
| $657K | ﹤0.01% |
28,513
+5,655
| +25% | +$131K |
2025 Q1
5 quarters
|
|
Similar funds
&Partners's Q2 2026 Portfolio in Review
As of Q2 2026, &Partners held 2,595 positions worth $24.4B, up 20% from $20.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
&Partners deployed $1.89B of net new capital in Q2 2026, opening 200 new positions and adding to 1,495 existing holdings. Its largest new stake was iShares International Country Rotation Active ETF: 434,646 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Palo Alto Networks, an estimated $14.1M trimmed.
- &Partners's largest Q2 2026 buy was iShares International Country Rotation Active ETF: 434,646 shares worth $16M.
- &Partners added most to NVIDIA in Q2 2026, an estimated $71M increase.
- &Partners's biggest Q2 2026 reduction was Palo Alto Networks, cutting an estimated $14.1M.
- &Partners fully exited Avantis Core Fixed Income ETF in Q2 2026, selling an estimated $9.19M.
- &Partners's ten largest holdings make up 21% of its $24.4B portfolio in Q2 2026.
- &Partners opened 200 new positions and closed 86 in Q2 2026.
- &Partners's portfolio value rose 20% quarter-over-quarter to $24.4B.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.